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Systemic  cystic  angiomatosis  is  a  rare  disease,  which
corresponds  to  disseminated  angiomatous  or  lymphangioma-
tous  cysts  [1—4].  Although  this  disease  mainly  develops
in  the  skeletal  structures,  visceral  involvement  can  occur.
The  imaging  features  of  systemic  cystic  angiomatosis  can
mimic  and  be  mistakenly  diagnosed  as  a  primary  carcinoma
with  disseminated  secondary  skeletal  involvement.  Histo-
logically,  the  diagnosis  is  difﬁcult.  We  report  the  case  of
a  57-year-old  man  with  systemic  cystic  angiomatosis  pre-
senting  with  typical  skeletal  and  splenic  involvement,  which
was  discovered  incidentally.
Case  study
A  58-year-old  man  presented  to  the  emergency  room  for
assessment  of  suspected  infectious  lung  disease.  Chest  X-
rays  revealed  an  asymptomatic  centimetric  area  of  bone
loss  on  the  left  rib.  Chest  and  abdominopelvic  computed
tomography  (CT)  was  performed  as  well  as  a  whole  body
MR  imaging  examination  (Fig.  1).  They  revealed  multiple
areas  of  bone  loss  mainly  in  the  axial  skeleton  and  the
ribs.  The  appearance  of  the  lytic  lesion  suggested  a  ‘‘pin
head’’  arrangement  in  certain  areas.  MR  imaging  showed
splenomegaly  associated  with  numerous  splenic  nodules  pre-
senting  with  heterogenous  enhancement.  Serum  protein
electrophoresis  was  normal  and  there  was  no  inﬂamma-
tory  syndrome.  PET-CT  showed  non-speciﬁc,  moderately
increased  metabolic  activity  in  certain  areas  of  bone  loss.
Three  PET-CT  guided  biopsies,  which  were  at  ﬁrst  incon-
clusive,  ﬁnally  suggested  the  diagnosis  of  systemic  cystic
angiomatosis  (Fig.  2).  Histopathologically  the  lesions  corre-
sponded  to  lymphangiomatous-type  dilation  of  the  vascular
spaces  (Fig.  3).  No  treatment  was  initiated.  The  patient,
who  was  asymptomatic,  will  undergo  splenic  ultrasound  and
radiographic  bone  assessment  every  6  months  as  long  as  he
remains  asymptomatic.
Discussion
Systemic  cystic  angiomatosis  is  a  rare  entity  that  is  mainly
characterized  by  disseminated  and  multifocal  lytic  lesions,
but  which  may  be  associated  with  visceral  involvement.
Several  organs  may  be  affected,  including  the  lungs,  kid-
neys,  spleen,  colon,  small  bowel  and  skin  [1—3]. The  exact
pathogenic  etiology  of  this  disease  is  unknown;  it  seems  to
be  associated  with  sequestration  of  liquid  in  the  lymphatic
system  during  embryogensis  [5].  Skeletal  involvement  is  pre-
dominant.
Systemic  cystic  angiomatosis  has  been  referred  to  either
angiomatosis  or  lymphangiomatosis.  This  is  because  vascular
dilations  may  contain  blood  or  lymph  [4,5].
CT  usually  shows  vertebral  involvement  with  bone  loss
and  osteosclerotic  radiolucencies.  In  the  axial  plane,  CTFigure 1. Whole body CT and MR imaging examination: a: in the coro
osteosclerosis. Multinodular splenic involvement is present; b: in the ax
‘‘pin head’’ arrangement in certain areas suggesting a vertebral angiom
150) in the coronal plane shows multiple lytic bone lesions displaying hynal plane, CT shows lytic vertebral and rib lesions with peripheral
ial plane at the level of L1 vertebra, CT shows a lytic lesion with
a; c: fat-suppressed T2-weighted MR image (TE: 64; TR: 4000; Ti:
persignal associated with multinodular splenic involvement.
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ease  but  a  careful  analysis  of  patient  history  and  imaging
features  help  suggest  the  diagnosis  which  is  often  difﬁcult
to  conﬁrm  on  histology.igure 2. 18 FDG PET-CT guided biopsy (a) of a lytic lesion with m
hows  dense  bone  with  areas  of  bone  loss  as  a  ‘‘pin  head’’
rrangement.  In  the  sagittal  plane,  CT  shows  ‘‘vertical
tripes’’.
MR  imaging  usually  shows  hypersignal  on  T1-  and  T2-
eighted  images  in  relation  to  the  presence  of  fat  as  well  as
ild  enhancement  after  IV  administration  of  a  gadolinium
helate  [6].
Lesions  are  non-speciﬁc  on  18-FDG  PET-CT,  with  no
etabolic  activity  and  even  moderately  increased  non-
athological  metabolic  activity.
The  possible  differential  diagnoses  in  the  presence  of
isseminated  lytic  angiomatous  features  include  histiocy-
osis  X,  hyperparathyroidism,  polyostotic  ﬁbrous  dysplasia,
etastases  and  lymphomas  [4,7,8].  Nevertheless  for  all
hese  conditions,  the  radiolucent  area  of  osteosclerosis
s  often  absent  and  the  typical  angiomatous  presentation
escribed  above  is  not  present.
Visceral  involvement  is  more  rare  and  can  be  life
hreatening.  In  our  patient,  splenic  involvement  may
ause  splenomegaly,  coagulation  disorders  and  even  life-
hreatening  splenic  rupture.  On  MR  imaging  and  CT  splenic
nvolvement  usually  presents  as  multiple  slightly  enhancing
odules  [9].
Patients  with  systemic  cystic  angiomatosis  are  often
symptomatic  and  the  disease  is  often  discovered  inciden-
ally  following  a  pathological  fracture  revealing  dissemi-
ated  skeletal  involvement,  which  is  at  ﬁrst  mistakenly
hought  to  be  neoplastic.
The  diagnosis  of  systemic  cystic  angiomatosis  is  obtained
rom  a  bone  biopsy.  Nevertheless,  as  reported  in  the  lit-
rature  and  conﬁrmed  in  our  patient,  the  histological
iagnosis  is  difﬁcult,  and  several  biopsies  are  often  needed
o  reach  the  ﬁnal  diagnosis  [4,6].  The  main  role  of  imag-
ng  is  thus  to  suggest  the  diagnosis  to  guide  the  pathologist
F
f
drate uptake on PET-CT allowed deﬁnite diagnosis (b).
hus  avoiding  invasive  procedures  and  their  associated
isks.
There  is  no  conﬁrmed  treatment  of  systemic  angiomato-
is  to  date.  Some  authors  have  reported  treatment  with
iphosphonates  [10].  In  our  patient,  we  have  decided  to
erform  biannual  ultrasound  monitoring  of  the  spleen  and
nnual  radiological  assessment  of  bone  lesions.  The  patient
s  asymptomatic  at  present,  but  the  splenic  visceral  involve-
ent  makes  the  long-term  prognosis  guarded.
In  conclusion,  systemic  cystic  angiomatosis  is  a  rare  dis-igure 3. Histopathological analysis of tissue sample obtained
rom PET-CT guided biopsy (HES, original magniﬁcation × 20) shows
ilated lymphangiomatous vascular spaces.
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